Potential uses of polyethylene glycol conjugated recombinant IL-2 in common variable immunodeficiency

Immunodeficiency. 1993;4(1-4):31-6.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • B-Lymphocytes / immunology
  • Common Variable Immunodeficiency / immunology
  • Common Variable Immunodeficiency / therapy*
  • Hemocyanins / immunology
  • Humans
  • Immunization
  • Immunoglobulins / biosynthesis
  • In Vitro Techniques
  • Injections, Intravenous
  • Injections, Subcutaneous
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / analogs & derivatives*
  • Interleukin-2 / biosynthesis
  • Interleukin-2 / deficiency
  • Interleukin-2 / therapeutic use
  • Phytohemagglutinins / pharmacology
  • Polyethylene Glycols
  • Staphylococcus aureus / immunology
  • T-Lymphocytes / immunology

Substances

  • Immunoglobulins
  • Interleukin-2
  • Phytohemagglutinins
  • interleukin-2, polyethylene glycol-modified
  • Polyethylene Glycols
  • Hemocyanins
  • keyhole-limpet hemocyanin